Janney Montgomery Scott’s OptimizeRx OPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$778K Buy
+135,969
New +$782K ﹤0.01% 2079
2025
Q2
Sell
-124,751
Closed -$1.08M 2798
2025
Q1
$1.08M Buy
124,751
+39,969
+47% +$244K ﹤0.01% 1491
2024
Q4
$412K Sell
84,782
-20,135
-19% -$113K ﹤0.01% 2113
2024
Q3
$810K Buy
+104,917
New +$933K ﹤0.01% 1643

Other funds holding OPRX

Janney Montgomery Scott's OPRX Position: Q2 2026 in Review

Janney Montgomery Scott opened a new position in OptimizeRx (OPRX) in Q2 2026: 135,969 shares worth $778K. The stake represents ﹤0.01% of the portfolio and ranks #2079 among its holdings. This is a return to the name: Janney Montgomery Scott previously reported a position in OPRX as recently as Q1 2025.

Janney Montgomery Scott first reported a position in OPRX in Q3 2024 and has held it in 4 quarters since. The position peaked at $1.08M in Q1 2025. 112 funds tracked by Wall St. Rank hold OPRX as of Q2 2026.

  • Janney Montgomery Scott held 135,969 shares of OptimizeRx worth $778K as of Q2 2026.
  • OptimizeRx was a new Janney Montgomery Scott position in Q2 2026.
  • OptimizeRx made up ﹤0.01% of Janney Montgomery Scott's portfolio in Q2 2026, its #2079 holding.
  • Janney Montgomery Scott first reported a position in OptimizeRx in Q3 2024 and has held it in 4 quarters since.
  • Janney Montgomery Scott's OptimizeRx position peaked at $1.08M in Q1 2025.
  • 112 funds tracked by Wall St. Rank held OptimizeRx as of Q2 2026.

Based on Janney Montgomery Scott's 13F filing for Q2 2026, filed 5 Aug 2026.